CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

January 31, 2041

Conditions

Glioblastoma Multiforme of Brain

Interventions

BIOLOGICAL

CHM-1101 CAR-T cells

Administered via ICT/ICV dual delivery

Trial Locations (2)

St. David's South Austin Medical Center - Sarah Cannon - Austin, Austin

City of Hope Medical Center, Duarte